Motus GI Holdings has developed the Pure-Vu System, a medical device that has been cleared to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area for use in colonoscopy. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Through irrigation and evacuation of debris, the Pure-Vu System is designed to provide exams. We show 20 historical shares outstanding datapoints in our MOTS shares outstanding history coverage, used to compute MOTS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing MOTS market cap history over the course of time is important for investors
interested in comparing MOTS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of MOTS versus a peer is one thing; comparing
MOTS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like MOTS can fluctuate over the course of history.
With this page we aim to empower investors researching MOTS by allowing them to research the MOTS market cap history. |
Free MOTS Email Alerts:
Video: The Importance of Market Cap
